Three new cancer drugs given go-ahead for routine use in Scotland
Three new cancer drugs have been given the go-ahead for routine use in Scotland, the Scottish Medicines Consortium has announced. Lung cancer drugs Osimertinib (Tagrisso) and Atezolizumab (Tecentriq) were cleared
Read More